Toxic or drug-related embryofetopathy
MONDO:0016677Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
21 clinical trials for this condition and its sub-types, 2 tagged with Toxic or drug-related embryofetopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Toxic or drug-related embryofetopathy
-
Fetal alcohol syndrome 17 trials
-
Thalidomide embryopathy 1 trial
-
Fetal trimethadione syndrome 0 trials · 1 incl. sub-types
1 sub-type
- German syndrome 1 trial
-
Acitretin/etretinate embryopathy 0 trials
-
Cocaine embryofetopathy 0 trials
-
Diethylstilbestrol syndrome 0 trials
-
Fetal carbamazepine syndrome 0 trials
-
Fetal hydantoin syndrome 0 trials
-
Fetal iodine syndrome 0 trials
-
Fetal methylmercury syndrome 0 trials
-
Fetal minoxidil syndrome 0 trials
-
Fetal phenothiazine syndrome 0 trials
-
Fetal valproate syndrome 0 trials
-
Indomethacin embryofetopathy 0 trials
-
Isotretinoin syndrome 0 trials
-
Methimazole embryofetopathy 0 trials
-
Mycophenolate mofetil embryopathy 0 trials
-
Phenobarbital embryopathy 0 trials
-
Propylthiouracil embryofetopathy 0 trials
-
Toluene embryopathy 0 trials
-
Vitamin K-antagonist embryofetopathy 0 trials
-
Night help for moms in recovery: can respite care improve sleep and Well-Being?
Symptom relief CompletedThis study tested whether providing overnight infant care and parenting support helps new mothers with substance use disorder living in residential treatment programs. 41 mothers participated, and researchers measured how many enrolled, completed the program, and gave feedback. T…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Hormone shield: could progesterone or testosterone guard against Drug-Induced heart risks?
Knowledge-focused CompletedThis study looked at whether taking progesterone (in women) or testosterone (in men) could reduce dangerous changes in heart rhythm caused by certain medications. 73 healthy older adults (postmenopausal women and men 65+) took either the hormone or a placebo, then received a smal…
Phase 4 • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC